Shared on04 Aug 25Fair value Increased 8.43%
Upward revisions to Xylem's revenue growth forecasts and net profit margins have driven an increase in the consensus analyst price target from $145.31 to $157.31. What's in the News Xylem raised its 2025 revenue guidance to $8.9–9.0 billion, now expecting 4–5% reported growth versus prior 1–2% guidance.
Shared on30 Apr 25Fair value Decreased 0.15%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25Fair value Decreased 2.88%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on16 Apr 25Fair value Decreased 1.22%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 1.61%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 0.30%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Increased 2.85%
AnalystConsensusTarget has decreased revenue growth from 4.7% to 4.1%.